05:50 PM EST, 03/04/2024 (MT Newswires) -- N Anthony Coles, Director, on February 29, 2024, sold 50,000 shares in Cerevel Therapeutics Holdings ( CERE ) for $2,057,890. Following the Form 4 filing with the SEC, Coles has control over a total of 15,638 shares of the company, with 15,638 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1805387/000095017024025036/xslF345X03/ownership.xml